deltatrials

Stanford University Clinical Trials

Sponsors / Stanford University

Stanford University is listed as the lead sponsor on 1,249 clinical trials registered with ClinicalTrials.gov. 150 trials are actively recruiting participants, 49 remain active without open enrollment, and 747 have concluded. 138 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 4,302,581 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.

1,249
Total Trials
150
Recruiting
49
Other Active
747
Completed
138
Terminated / Withdrawn
4,302,581
Total Enrollment

Termination reasons: Other46% · Recruitment33% · Funding7% · Business5% · PI/or_Site3% · Efficacy3% · Safety1% · Regulatory1%

Recent Terminations

  • NCT07071129 Phase NA Stopped Sep 2025
    Glaucoma
    "Due to Covid pandemic"
  • NCT05413928 Stopped Oct 2024
    Healthy
    "The study was stopped due to insufficient dietary differences, loss of support for the sleep device after acquisition, and high variability in temperature data, all these prevented meaningful evaluation of study aims."
  • NCT06078501 Phase PHASE3 Stopped Jul 2024
    Blood Loss, Surgical
    "Recruitment not feasible for this patient population within study timeframe"
  • NCT04943744 Phase EARLY_PHASE1 Stopped May 2024
    Eosinophilic Disorder
    "Parent study closed to enrollment"
  • NCT05071820 Phase NA Stopped Sep 2023
    Elevated Blood Sugar
    "The investigators decided to halt the study early because the company delivering the microlearning platform was incorporated into another company."
  • NCT04954248 Phase NA Stopped Sep 2023
    Brain Diseases
    "The associated funding source was ended, and the proposed duration of the study ended."
  • NCT05509738 Phase NA Stopped Mar 2023
    Behavior Change Techniques
    "Slow Recruitment"
  • NCT04891263 Phase NA Stopped Sep 2021
    Nasal Obstruction
    "Recruitment difficulties due to COVID-19 pandemic"
  • NCT05809245 Phase NA Stopped Feb 2020
    Cranial Nerve V Diseases
    "Difficulties with recruitment"
  • NCT05088447 Stopped Mar 2017
    Cystic Fibrosis
    "Change in research plan"

Active Trials (49 total)

See all 49 active trials

Top Conditions

Breast cancer (31) Anxiety (20) Pain (18) Depression (17) Chronic pain (14) Cancer (12) Autism (11) Parkinson's disease (11) Anesthesia, local (9) Lung cancer (9)

Top Locations

Stanford, United States (740) Palo Alto, United States (354) Redwood City, United States (50) San Francisco, United States (16) Los Angeles, United States (7) Chicago, United States (6) Philadelphia, United States (6) Salt Lake City, United States (6) San Jose, United States (6) St. Louis, United States (6)